Skip to main content
Premium Trial:

Request an Annual Quote

That's One Famous Embryo

There was a lot of attention this weekend to the first baby born in Britain who was screened as an embryo for BRCA1. "The decision was a controversial one, raising arguments that this type of screening is one step on a slippery slope towards eugenics," reports Technology Review. "Pre-implantation genetic diagnosis, as the procedure is called, has traditionally been limited to genetic disorders known to be fatal. But as the number of known disease-linked genes grows, so do the options for testing."

This article in the Guardian says that the newborn "is not a designer baby in the strict sense of the phrase." In the UK, the group in charge of regulating in vitro fertilization practices "held a public consultation before deciding to grant permission for PGD to be carried out to screen for the breast cancer genes," the story adds.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.